Eubiologics seeks to hold local phase three clinical trials of its shot called Eucorvac-19.
Let's find out more from Seok Kyu Kim, the General Manager of Eubiologics and Giovanni Alingong, the CEO of its Philippine partner, Glovax Biotech Corporation.
Visit our website for more #NewsYouCanTrust: https://www.cnnphilippines.com/
Follow our social media pages:
• Facebook: https://www.facebook.com/CNNPhilippines
• Instagram: https://www.instagram.com/cnnphilippines/
• Twitter: https://twitter.com/cnnphilippines